Search research articles
Contact Us
Filters
Showing results (211-220 of 219) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 219 results.
Journal of the National Cancer Institute
|
February 5, 1998
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells
W Shao, M Fanelli, F F Ferrara, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1997
Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes
M Yu, J H Tong, M Mao, et al.
Journal of the National Cancer Institute
|
May 18, 1999
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations
X H Zhu, Y L Shen, Y K Jing, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 29, 1999
Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene
T Zhang, H Xiong, L X Kan, et al.
Nature Communications
|
April 23, 2025
Nkx2.7 is a conserved regulator of craniofacial development
Caitlin Ford, Carmen de Sena-Tomás, Tint Tha Ra Wun, et al.
Leukemia
|
March 11, 2005
Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries
B Chen, W-L Zhao, J Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 1999
Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha
G X Cheng, X H Zhu, X Q Men, et al.
Blood
|
May 1, 1997
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells
G Q Chen, X G Shi, W Tang, et al.
Blood
|
November 24, 1999
Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
C Niu, H Yan, T Yu, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 219) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 219 results.
Journal of the National Cancer Institute
|
February 5, 1998
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells
W Shao, M Fanelli, F F Ferrara, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1997
Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes
M Yu, J H Tong, M Mao, et al.
Journal of the National Cancer Institute
|
May 18, 1999
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations
X H Zhu, Y L Shen, Y K Jing, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 29, 1999
Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene
T Zhang, H Xiong, L X Kan, et al.
Nature Communications
|
April 23, 2025
Nkx2.7 is a conserved regulator of craniofacial development
Caitlin Ford, Carmen de Sena-Tomás, Tint Tha Ra Wun, et al.
Leukemia
|
March 11, 2005
Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries
B Chen, W-L Zhao, J Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 1999
Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha
G X Cheng, X H Zhu, X Q Men, et al.
Blood
|
May 1, 1997
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells
G Q Chen, X G Shi, W Tang, et al.
Blood
|
November 24, 1999
Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
C Niu, H Yan, T Yu, et al.
Page
of 22